Literature DB >> 17171345

Multiple sclerosis associated with systemic sclerosis.

Syngliti-Henrietta Pelidou1, Niki Tsifetaki, Sotiris Giannopoulos, Georgia Deretzi, Paraskevi Voulgari, Athanassios Kyritsis.   

Abstract

Multiple sclerosis (MS) has been increasingly reported in association with other autoimmune diseases not primary affected the nervous system. The coexistence of MS and systemic sclerosis (SSc) has been rarely described. We report here the case of a 46-year-old female patient with longstanding MS since the age of 26, who developed SSc 12 years later. Her MS was of the relapsing-remitting type, but the definite diagnosis was not made until the age of 33. MS diagnosis was based on medical history, magnetic resonance imaging (MRI) studies and positive cerebrospinal fluid analysis. One year after the diagnosis of MS, she developed Raynaud's phenomenon, skin tightness and hypopigmented patches, suggestive of scleroderma. Further investigation with laboratory studies, including serology, hand and chest X-rays, and chest computerized tomography scan confirmed the SSc diagnosis. Our report highlights the interesting association between MS and SSc that may be due to an overlapping pathogenetic mechanism for both processes.

Entities:  

Mesh:

Year:  2006        PMID: 17171345     DOI: 10.1007/s00296-006-0282-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  17 in total

1.  Systemic sclerosis and multiple sclerosis.

Authors:  A Spadaro; F Sensi; M Barrella; A Francia
Journal:  J Neurol       Date:  1999-06       Impact factor: 4.849

2.  The 77C->G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis.

Authors:  Hue-Tran Do; Wiebke Baars; Katja Borns; Anja Windhagen; Reinhard Schwinzer
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  Case history of a patient with multiple sclerosis and scleroderma.

Authors:  S H Jawad; A Askari; A B Ward
Journal:  Br J Rheumatol       Date:  1997-04

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Overlap syndromes in the context of shared autoimmunity.

Authors:  Tatiana Sofía Rodríguez-Reyna; Donato Alarcón-Segovia
Journal:  Autoimmunity       Date:  2005-05       Impact factor: 2.815

6.  Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.

Authors:  R Schwinzer; T Witte; J Hundrieser; S Ehlers; T Momot; N Hunzelmann; T Krieg; R E Schmidt; K Wonigeit
Journal:  Genes Immun       Date:  2003-03       Impact factor: 2.676

7.  Multiple sclerosis and other immunologic diseases.

Authors:  S Seyfert; P Klapps; C Meisel; T Fischer; U Junghan
Journal:  Acta Neurol Scand       Date:  1990-01       Impact factor: 3.209

Review 8.  Demyelination in rheumatic diseases.

Authors:  A Theodoridou; L Settas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 9.  CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development.

Authors:  I S Trowbridge; M L Thomas
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

10.  Co-twin control study on cerebral manifestations of systemic lupus erythematosus.

Authors:  E Kinnunen; P Järvinen; L Ketonen; R Sepponen
Journal:  Acta Neurol Scand       Date:  1993-12       Impact factor: 3.209

View more
  5 in total

Review 1.  Multiple Sclerosis and Autoimmunity: A Veiled Relationship.

Authors:  Zineb Barkhane; Jalal Elmadi; Lakshmi Satish Kumar; Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy
Journal:  Cureus       Date:  2022-04-19

2.  Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.

Authors:  Nilufer Kale; Murat Icen; Jale Agaoglu; Isil Yazici; Osman Tanik
Journal:  Neurol Sci       Date:  2008-10-14       Impact factor: 3.307

3.  Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients.

Authors:  Maryam Zarrabi; Mohammadali Nazarinia; Abbas Rahimi Jaberi; Nasser Gholijani; Zahra Amirghofran
Journal:  Med Princ Pract       Date:  2020-10-20       Impact factor: 1.927

4.  Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis.

Authors:  Paolo Airo'; Mirko Scarsi; Mara Rossi; Michele Mondini
Journal:  Rheumatol Int       Date:  2007-12-08       Impact factor: 2.631

5.  The Inflammatory Conspiracy in Multiple Sclerosis: A Crossroads of Clues and Insights through Mast Cells, Platelets, Inflammation, Gut Microbiota, Mood Disorders and Stem Cells.

Authors:  Massimo Cocchi; Elisabetta Mondo; Marcello Romeo; Giovanna Traina
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.